Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07059221
What this trial is testing

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT04474470
What this trial is testing

Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

Who this might be right for
Solid Tumor, AdultSquamous Cell Carcinoma of Head and NeckColorectal Adenocarcinoma+3 more
TyrNovo Ltd. 52
Not applicableStudy completedNCT00899769
What this trial is testing

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00004865
What this trial is testing

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Who this might be right for
Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03226756
What this trial is testing

Nivolumab in Recurrent and/or Metastatic SCCHN

Who this might be right for
Recurrent and/or Metastatic Platinum-refractory SCCHN
UNICANCER 351
Large-scale testing (Phase 3)Study completedNCT00460265
What this trial is testing

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent and/or Metastatic Head and Neck Cancer
Amgen 658
Large-scale testing (Phase 3)Study completedNCT00090337
What this trial is testing

Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer

Who this might be right for
Head and Neck CancerPain
Memorial Sloan Kettering Cancer Center 73
Not applicableStudy completedNCT00896675
What this trial is testing

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 352
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290
What this trial is testing

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more
Roswell Park Cancer Institute 51
Not applicableLooking for participantsNCT07546383
What this trial is testing

A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
The Second Affiliated Hospital of Hainan Medical University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06857279
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma of Head and/or Neck
Shanghai Henlius Biotech 167
Testing effectiveness (Phase 2)Ended earlyNCT04242173
What this trial is testing

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck
H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Study completedNCT06446570
What this trial is testing

Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma

Who this might be right for
HNSCCHead and Neck Neoplasms
Seoul National University Hospital 18
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT04868162
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Lepu Biopharma Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT03433027
What this trial is testing

BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Benitec Biopharma, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT00005035
What this trial is testing

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03109158
What this trial is testing

NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
NanoCarrier Co., Ltd. 1
Testing effectiveness (Phase 2)Looking for participantsNCT06597565
What this trial is testing

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 43
Next Page